Cargando…
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
Redirection of immune cells to efficiently eliminate tumor cells holds great promise. Natural killer cells (NK), macrophages, or T cells are specifically engaged with target cells expressing markers after infection or neoplastic transformation, resulting in their activation and subsequent killing of...
Autores principales: | Ellwanger, Kristina, Reusch, Uwe, Fucek, Ivica, Wingert, Susanne, Ross, Thorsten, Müller, Thomas, Schniegler-Mattox, Ute, Haneke, Torsten, Rajkovic, Erich, Koch, Joachim, Treder, Martin, Tesar, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601565/ https://www.ncbi.nlm.nih.gov/pubmed/31172847 http://dx.doi.org/10.1080/19420862.2019.1616506 |
Ejemplares similares
-
Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors
por: Wingert, Susanne, et al.
Publicado: (2021) -
Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers
por: Reusch, Uwe, et al.
Publicado: (2022) -
Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method
por: Müller, Thomas, et al.
Publicado: (2023) -
Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
por: Ellwanger, Kristina, et al.
Publicado: (2017) -
EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors
por: Ellwanger, Kristina, et al.
Publicado: (2015)